Richard J. O’Reilly

17.8k total citations · 1 hit paper
295 papers, 10.7k citations indexed

About

Richard J. O’Reilly is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Richard J. O’Reilly has authored 295 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Hematology, 121 papers in Immunology and 119 papers in Oncology. Recurrent topics in Richard J. O’Reilly's work include Hematopoietic Stem Cell Transplantation (117 papers), Cytomegalovirus and herpesvirus research (69 papers) and Immune Cell Function and Interaction (58 papers). Richard J. O’Reilly is often cited by papers focused on Hematopoietic Stem Cell Transplantation (117 papers), Cytomegalovirus and herpesvirus research (69 papers) and Immune Cell Function and Interaction (58 papers). Richard J. O’Reilly collaborates with scholars based in United States, Spain and United Kingdom. Richard J. O’Reilly's co-authors include Nancy A. Kernan, Bo Dupont, Ekaterina Doubrovina, Katharine C. Hsu, Farid Boulad, Esperanza B. Papadopoulos, Guenther Koehne, Glenn Heller, James W. Young and Trudy N. Small and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Richard J. O’Reilly

288 papers receiving 10.3k citations

Hit Papers

Infusions of Donor Leukocytes to Treat Epstein-Barr Virus... 1994 2026 2004 2015 1994 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation
    1994 809 citations Farid Boulad, Nancy A. Kernan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard J. O’Reilly United States 54 5.0k 3.9k 3.8k 2.4k 1.6k 295 10.7k
Robert A. Krance United States 43 3.1k 0.6× 3.0k 0.8× 5.8k 1.5× 3.1k 1.3× 2.7k 1.7× 197 11.0k
Karl S. Peggs United Kingdom 54 5.9k 1.2× 2.4k 0.6× 6.9k 1.8× 2.1k 0.9× 1.3k 0.9× 200 12.0k
Paul Veys United Kingdom 52 3.0k 0.6× 3.5k 0.9× 1.9k 0.5× 1.6k 0.7× 1.7k 1.1× 186 7.7k
J.H. Frederik Falkenburg Netherlands 53 5.4k 1.1× 3.6k 0.9× 3.7k 1.0× 965 0.4× 1.4k 0.9× 280 9.1k
Mine Harada Japan 49 3.7k 0.7× 2.7k 0.7× 2.7k 0.7× 1.4k 0.6× 752 0.5× 375 10.2k
Arjan C. Lankester Netherlands 50 3.0k 0.6× 2.7k 0.7× 2.1k 0.6× 1.2k 0.5× 1.3k 0.8× 231 7.8k
Reuven Or Israel 44 3.5k 0.7× 6.6k 1.7× 2.6k 0.7× 1.4k 0.6× 648 0.4× 303 10.8k
A. Benedict Cosimi United States 65 4.2k 0.8× 1.6k 0.4× 2.2k 0.6× 3.3k 1.4× 876 0.6× 286 15.3k
Takanori Teshima Japan 52 5.0k 1.0× 5.6k 1.4× 2.5k 0.7× 1.1k 0.4× 533 0.3× 486 10.6k
Crystal L. Mackall United States 61 8.5k 1.7× 2.3k 0.6× 7.1k 1.9× 1.3k 0.5× 1.7k 1.1× 168 16.1k

Countries citing papers authored by Richard J. O’Reilly

Since Specialization
Citations

This map shows the geographic impact of Richard J. O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. O’Reilly more than expected).

Fields of papers citing papers by Richard J. O’Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. O’Reilly. The network helps show where Richard J. O’Reilly may publish in the future.

Co-authorship network of co-authors of Richard J. O’Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. O’Reilly. A scholar is included among the top collaborators of Richard J. O’Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. O’Reilly. Richard J. O’Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Klein, Elizabeth, Audrey Mauguen, Jaap Jan Boelens, et al.. (2023). T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML. Bone Marrow Transplantation. 59(1). 23–33. 1 indexed citations
3.
Klatt, Martin G., et al.. (2023). The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles. Journal for ImmunoTherapy of Cancer. 11(9). e006889–e006889. 4 indexed citations
4.
Dvorak, Christopher C., Élie Haddad, Jennifer Heimall, et al.. (2022). The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions. Journal of Allergy and Clinical Immunology. 151(2). 539–546. 53 indexed citations
5.
Fabrizio, Vanessa A., Audrey Mauguen, Parastoo B. Dahi, et al.. (2021). Baseline Immune Status As a Corollary to Response to Adoptive Therapy with CMV or EBV CTLs. Transplantation and Cellular Therapy. 27(3). S344–S345. 1 indexed citations
6.
Prockop, Susan E., Robert A. Baiocchi, Nancy Bunin, et al.. (2018). Efficacy and Safety of ATA129, Partially Matched Allogeneic Third-Party Epstein-Barr Virus-Targeted Cytotoxic T Lymphocytes in a Multicenter Study for Post-Transplant Lymphoproliferative Disorder. Biology of Blood and Marrow Transplantation. 24(3). S41–S42. 6 indexed citations
7.
Modak, Shakeel, Jean-Benoît Le Luduec, Irene Y. Cheung, et al.. (2018). Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study. OncoImmunology. 7(8). e1461305–e1461305. 70 indexed citations
8.
Gulati, Nitya, Farid Boulad, Maria Cancio, et al.. (2017). Brentuximab Vedotin Plus Bendamustine Is an Effective Salvage Regimen for Pediatric Patients with Relapsed Hodgkin Lymphoma. Blood. 130. 5172–5172. 1 indexed citations
9.
10.
Shono, Yusuke, Andrea Z. Tuckett, Hsiou‐Chi Liou, et al.. (2016). Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB–Controlled Oxidative Stress Responses. Cancer Research. 76(2). 377–389. 33 indexed citations
11.
Veomett, Nicholas, Tao Dao, Hong Liu, et al.. (2014). Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein. Clinical Cancer Research. 20(15). 4036–4046. 41 indexed citations
12.
Shono, Yusuke, Andrea Z. Tuckett, Samedy Ouk, et al.. (2014). A Small-Molecule c-Rel Inhibitor Reduces Alloactivation of T Cells without Compromising Antitumor Activity. Cancer Discovery. 4(5). 578–591. 42 indexed citations
13.
Barker, Juliet N., Ekaterina Doubrovina, Craig S. Sauter, et al.. (2010). Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes. Blood. 116(23). 5045–5049. 163 indexed citations
14.
Zanzonico, Pat, Guenther Koehne, Humilidad F. Gallardo, et al.. (2006). [131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity. European Journal of Nuclear Medicine and Molecular Imaging. 33(9). 988–997. 30 indexed citations
15.
Doubrovina, Ekaterina, Mikhail Doubrovin, Jelena Vider, et al.. (2003). Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma. The Journal of Immunology. 171(12). 6891–6899. 267 indexed citations
16.
Hsu, Katharine C., Xiaorong Liu, Annamalai Selvakumar, et al.. (2002). Killer Ig-Like Receptor Haplotype Analysis by Gene Content: Evidence for Genomic Diversity with a Minimum of Six Basic Framework Haplotypes, Each with Multiple Subsets. The Journal of Immunology. 169(9). 5118–5129. 335 indexed citations
17.
Prasad, Vinod K., Glenn Heller, Nancy A. Kernan, Richard J. O’Reilly, & Soo Young Yang. (1999). THE PROBABILITY OF HLA-C MATCHING BETWEEN PATIENT AND UNRELATED DONOR AT THE MOLECULAR LEVEL. Transplantation. 68(7). 1044–1050. 26 indexed citations
18.
Zhang, Mei‐Jie, Michele Baccarani, Robert Peter Gale, et al.. (1997). Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy. British Journal of Haematology. 99(1). 23–29. 2 indexed citations
19.
Nahmias, André J. & Richard J. O’Reilly. (1982). Viruses and parasites : Immunodiagnosis and prevention of infectious diseases. 2 indexed citations
20.
Nahmias, André J. & Richard J. O’Reilly. (1981). Bacteria, Mycoplasmae, Chlamydiae, and Fungi. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert A. Krance Breakdown of academic impact, for papers by Karl S. Peggs Breakdown of academic impact, for papers by Paul Veys Breakdown of academic impact, for papers by J.H. Frederik Falkenburg Breakdown of academic impact, for papers by Mine Harada Breakdown of academic impact, for papers by Arjan C. Lankester Breakdown of academic impact, for papers by Reuven Or Breakdown of academic impact, for papers by A. Benedict Cosimi Breakdown of academic impact, for papers by Takanori Teshima Breakdown of academic impact, for papers by Crystal L. Mackall
Rankless by CCL
2026